Founded with a mission to combat hypertension and cardiovascular disease, CardieX is a global health technology company dedicated to developing innovative solutions for vascular health disorders. The company offers a range of products and services, including CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2, which cater to healthcare, drug and device development, academia/research, and wellness sectors. CardieX aims to improve patient outcomes through advanced diagnostic and monitoring technologies, focusing on conditions such as hypertension, renal disease, heart failure, and metabolic health.
CardieX has garnered attention through its impactful contributions to cardiovascular health, supported by a team of experienced board members and management. Notable achievements include the widespread adoption of their SphygmoCor technology in clinical settings and research institutions. The company has also formed strategic partnerships with key stakeholders in the healthcare industry, enhancing its influence and reach. Through its innovative solutions, CardieX continues to make significant strides in improving global cardiovascular health outcomes.
